Immunogenicity and reactogenicity of heterologous COVID-19 vaccination in pregnant women

• Päätekijät: Chenchit Chayachinda (Tekijä), Kanokwaroon Watananirun (Tekijä), Chayawat Phatihattakorn (Tekijä), Sanitra Anuwutnavin (Tekijä), Suvimol Niyomnaitham (Tekijä), Wanatpreeya Phongsamart (Tekijä), Keswadee Lapphra (Tekijä), Orasri Wittawatmongkol (Tekijä), Supattra Rungmaitree (Tekijä), Laddawan Jansarikit (Tekijä), Kobporn Boonnak (Tekijä), Patimaporn Wongprompitak (Tekijä), Sansnee Senawong (Tekijä), Avishek Upadhya (Tekijä), Zheng Quan Toh (Tekijä), Paul V. Licciardi (Tekijä), Kulkanya Chokephaibulkit (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Taylor & Francis Group, 2023-08-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

This open-labeled non-inferiority trial evaluated immunogenicity and reactogenicity of heterologous and homologous COVID-19 vaccination schedules in pregnant Thai women. 18-45-year-old pregnant women with no history of COVID-19 infection or vaccination and a gestational age of ≥12 weeks were randomi...